Effect of Therapeutic Touch on Labor Pain and Hormone Levels
The Effect of Sacral Region-focused Therapeutic Touch Applied During the Latent Phase of Labour on Hormone Levels, Labour Comfort and Perception: A Randomized Sham Controlled Trialt
1 other identifier
interventional
50
1 country
1
Brief Summary
This study was conducted to determine the effect of sacral region-focused therapeutic touch applied during the latent phase of labour on hormone levels, labour comfort, and perception. A randomized sham controlled trial design was used in the study, which was conducted with 50 primiparous pregnant women. While Therapeutic Touch (25) focused on sacral region was applied in the intervention group, Sham Therapeutic Touch (25) was applied in the control group. Data were collected using a Personal Information Form, the Visual Analogue Scale, a Hormone Values Follow-up Form, the Childbirth Comfort Questionnaire and the Perception of Birth Scale. Keywords: Labor Pain,Therapeutic Touch, Childbirth, Hormones
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 17, 2021
CompletedFirst Posted
Study publicly available on registry
January 6, 2022
CompletedStudy Start
First participant enrolled
March 8, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2023
CompletedAugust 23, 2024
February 1, 2024
1.1 years
December 17, 2021
August 20, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Visual Analogue Scale (VAS)
VAS is a one-dimensional scale that objectively assesses pregnant woman's perception of pain. VAS is a 100 mm scale (10-cm) that represents lack of pain (0=no pain) on one end and worst possible pain (10=severe pain) on the other end; the scale is used to determine the severity of pain quantitatively. The patient marks any point between the two ends that describe his/her pain severity. The point between lack of pain and the point indicated by the patient is measured using a ruler and recorded as cm. These numeric values indicate the pregnant woman's pain severity.
VAS were evaluated after application 30 minutes in each groups.
Secondary Outcomes (1)
The Perception of Birth Scale (PBS)
PBS were evaluated after delivery in each groups.
Other Outcomes (2)
The Childbirth Comfort Questionnaire (CCQ)
CCQ were evaluated after application 30 minutes in each groups.
Hormones
a maternal saliva sample for hormones was took pretest and posttest (after application in 30 minutes).
Study Arms (2)
Experimental Group
EXPERIMENTALThe experimental group will be administered 15-minute therapeutic touch focused on sacral region the latent phase and after it finishes, the participating pregnant woman will be asked to rest for 30 minutes.
Placebo Group
PLACEBO COMPARATORAfter the mimic (sham) therapeutic touch focused on sacral region , the pregnant woman will be asked to rest for 30 minutes.
Interventions
In the latent phase of labor, the field energy of the sacral region will be cleared for an average of 15 minutes.
Eligibility Criteria
You may qualify if:
- Being primipara,
- Having a gestational age of 38-42 weeks,
- Planning to have a normal vaginal delivery,
- Having a 3-4 cm dilation in the latent phase,
- Having a single fetus and head presentation,
- Speaking and communicating in Turkish,
- Agreeing to participate in the study,
- Having no high-risk pregnancy.
You may not qualify if:
- Receiving induction,
- Receiving labor analgesia/anesthesia,
- Having sensitivity or problems with touch,
- Having to leave during the intervention due to some reasons such as medical procedures, etc.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Cukurova University
Adana, Sarıcam, 01330, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ebru Gözüyeşil, PhD. Associate Professor,
Cukurova University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- In addition to ensuring the blinding of the participants in the study, blinding was also performed during the data collection, hormone values analysis, statistics and reporting stages. Women who agreed to participate in the study were not informed about the group they were assigned to. Since the participants did not know to which group they were assigned, the study was conducted in a single-blind design.
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Prof.
Study Record Dates
First Submitted
December 17, 2021
First Posted
January 6, 2022
Study Start
March 8, 2022
Primary Completion
April 1, 2023
Study Completion
April 1, 2023
Last Updated
August 23, 2024
Record last verified: 2024-02
Data Sharing
- IPD Sharing
- Will not share